5 Best Cancer Stocks To Buy Now

4. Bristol-Myers Squibb Company (NYSE:BMY)

Number of Hedge Fund Holders: 73

Bristol-Myers Squibb Company (NYSE:BMY) is a good investment option for income investors as the healthcare company offers a dividend yield of 3.40%. In the second quarter of 2021, the company’s revenue came in at $11.7 billion, beating estimates by $100 million. In Q2, the company’s leading cancer drugs, Revlimid and Opdivo, brought in $3.2 billion and $1.91 billion. 

At the end of June, 73 funds out of the 873 tracked by Insider Monkey had stakes in the company, compared to 81 in the previous quarter.

The New York-based pharmaceutical company is one of the best cancer stocks to buy now. On October 25, Citi analyst Andrew Baum maintained a Buy rating on Bristol-Myers Squibb Company (NYSE:BMY) with a price target of $75 per share.